HomeCLRB • NASDAQ
add
Cellectar Biosciences Inc
Previous close
$2.11
Day range
$2.06 - $2.13
Year range
$1.83 - $4.45
Market cap
86.00M USD
Avg Volume
224.92K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 13.70M | 65.22% |
Net income | -919.37K | 90.97% |
Net profit margin | — | — |
Earnings per share | -0.03 | 95.89% |
EBITDA | -13.64M | -65.20% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 25.87M | 402.02% |
Total assets | 29.38M | 351.44% |
Total liabilities | 15.62M | 123.93% |
Total equity | 13.76M | — |
Shares outstanding | 40.57M | — |
Price to book | 16.23 | — |
Return on assets | -94.78% | — |
Return on capital | -238.53% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -919.37K | 90.97% |
Cash from operations | -14.14M | -87.80% |
Cash from investing | -21.28K | — |
Cash from financing | 1.00 | — |
Net change in cash | -14.16M | -88.09% |
Free cash flow | -21.81M | -381.25% |
About
Founded
1996
Headquarters
Website
Employees
20
